Skip to main content

Table 6 Comparison of recurrence and death rates in premenopausal patients with breast cancer treated with tamoxifen (TAM) and toremifene (TOR)

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

 

TAM (n = 240)

TOR (n = 212)

P value

Overall survival(%)

97.9

100

0.087

3 years

99.5

100

 

5 years

98.4

100

 

8 years

95.5

100

 

Recurrence-free survival(%)

90.4

97.2

0.022

3 years

94.8

98.8

 

5 years

90.7

95.6

 

8 years

88.9

89.3

 
  1. Differences between the groups were evaluated using log-rank tests for unadjusted analyses.